Ac-225 Production via Neutron-Induced Gamma Irradiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The scarcity of Actinium-225 (Ac-225) limits its potential applications in Targeted Alpha Therapy due to its synthesis being constrained by the availability of Radium-226 (Ra-226), which is not adequately met by current production methods.
Innovation Solution
A method and system utilizing an electronic neutron generator or a nuclear reactor to generate thermal neutrons, which are used to produce gamma radiation that irradiates Ra-226, converting it into Ra-225, which then decays into Ac-225, leveraging Ra-226 from sources like flowback water from natural gas production processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If traditional production methods are used to synthesize Ac-225, then the process is constrained by the availability of Ra-226, but the supply of Ac-225 remains insufficient for widespread applications
Solution Approach 1:
The patent changes the production parameters by using neutron irradiation instead of traditional radioactive decay methods. By irradiating Ra-226 with neutrons in a nuclear reactor, the material undergoes transmutation to produce Ac-225, fundamentally altering the production mechanism to increase supply capability
Solution Approach 2:
The patent introduces an intermediary substance (neutrons) to facilitate the production process. Neutrons act as a mediator that transforms Ra-226 into Ac-225 through nuclear reactions, enabling controlled and scalable production that overcomes the limitations of direct decay methods
2Quantity of substance
If Ra-226 is used as the source material, then Ac-225 can be produced through decay, but the scarcity of Ra-226 limits the production scale
Solution Approach 1:
The patent replaces the passive radioactive decay mechanism with an active neutron irradiation process. This substitution allows for controlled transformation of Ra-226 into Ac-225, enabling better management of the Ra-226 resource and increasing production scalability
Solution Approach 2:
The patent changes the fundamental production parameter from relying on natural decay rates to using neutron-induced transmutation. This parameter change allows for accelerated and controlled production, overcoming the scarcity limitation of Ra-226
3Productivity
If conventional production methods are used, then the process is simple, but the output is insufficient for large-scale cancer treatment applications
Solution Approach 1:
The patent employs a nuclear reactor-based system that can produce multiple isotopes and serve multiple functions. The same irradiation facility can produce Ac-225 and other medical isotopes, increasing overall productivity and scalability for cancer treatment applications
Data Source
AI summary
Devices, systems, and methods to produce Ac-225 from Ra-226 using gamma-radiation generator are disclosed herein. The gamma radiation generator can utilize an electronic neutron generator or a nuclear reactor to produce high energy prompt-capture gamma-radiation. The Ra-226 is irradiated by the gamma radiation to produce Ra-225, which decays to produce Ac-225. The method of using electronic neutron generator and an irradiation target material such as Gd-157 to produce high energy gamma radiation without using a continuously decaying radioisotope such as Co-60 could significantly reduce the cost and increase the safety associated with the production of high energy gamma radiation and Ac-225.